IN SITU VACCINATION AGAINST A NON-IMMUNOGENIC TUMOUR USING INTRATUMOURAL INJECTIONS OF LIPOSOMAL INTERLEUKIN 2

T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity

Steven Gillis, Mary M. Ferm, Winny Ou et al. · The Journal of Immunology · 1978 · 3.3K citations · Full text

Life Sciences, Cell Biology, Immunology +13

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Anita B. Roberts, Michael B. Sporn, Richard K. Assoian et al. · Proceedings of the National Academy of Sciences · 1986 · 2.9K citations · Full text

Life Sciences, Cell Biology, Pathology +14

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al. · Proceedings of the National Academy of Sciences · 1993 · 2.8K citations

Medicine, Immunology, Oncology +17

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al. · Nature Medicine · 1998 · 1.8K citations

Medicine, Immunology, Oncology +16

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

S. Ansar Ahmed, Robert M. Gogal, Jane E. Walsh · Journal of Immunological Methods · 1994 · 1.4K citations

Life Sciences, Immunology, Clinical Immunology +4